InvestorsHub Logo

DewDiligence

03/22/23 5:18 PM

#51 RE: DewDiligence #48

ASBM 4Q22 results—12/31/22 cash=$92M—(down_from $109M @9/30/22):

https://finance.yahoo.com/news/assembly-biosciences-provides-core-inhibitor-200500620.html

No CC.